NAUT FY 2022 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

NAUTNautilus Biotechnology, Inc.

$339M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$3M

Operating Income

-$64M

Net Income

-$58M

EPS (Diluted)

$-0.46

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$48M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$350M

Total Liabilities

$35M

Stockholders' Equity

$315M

Cash & Equivalents

$115M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$3M	-$3M	-20.2%
Operating Income	-$64M	-$50M	-26.0%
Net Income	-$58M	-$50M	-15.1%